Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why ChemoCentryx Shares Are Popping Off

ChemoCentryx Inc (NASDAQ:CCXI) shares are trading higher by 21.45% at $19.00 after the company reported first-quarter results.

ChemoCentryx reported quarterly losses of 55 cents per share which missed the analyst consensus estimate of a loss of 30 cents. The company also reported quarterly sales of $5.46 million which missed the analyst consensus estimate of $22.04 million.

Raymond James analyst Steven Seedhouse maintained ChemoCentryx Friday morning with a Strong Buy and lowered the price target from $110 to $106.

See Also: Why DoorDash Shares Are Rising Today

ChemoCentryx is a biopharmaceutical company involved in the discovery, development and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases and cancer.

According to data from Benzinga Pro, ChemoCentryx has a 52-week high of $42.16 and a 52-week low of $9.53.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.